46 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
14 May 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
7:55am
talent to drive its mission of transforming cancer care through innovation.
Program and Corporate Updates
PYX-201 in the PYX-201-101 trial: To date
8-K/A
EX-99.2
998cjs
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K
EX-99.1
u9efwlb453rh4v2kq6
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
425
9gc3oj7yctpsnkpna44
11 Aug 23
Business combination disclosure
7:26am
8-K
EX-99.1
kytd4 o2nkb2yx25nvm
11 Aug 23
Pyxis Oncology Reports Financial Results for Second-Quarter 2023
7:25am
424B3
t0ls3psytz6
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
1drbd1e0pkn gve
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
gipmguovc4ntc0s
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
4pl6em161 s488b
25 May 23
Business combination disclosure
8:14am
425
vqpvtef2hi0g4f4i
24 May 23
Business combination disclosure
5:00pm
425
j280g aisil88rlwj
24 May 23
Business combination disclosure
7:05am
425
7mbugd cwr
24 May 23
Business combination disclosure
7:03am
8-K
EX-99.1
zmyc9dzx3ali 66h2wbk
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am